Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Prognostic Impact of Rare Single Abnormalities in Myelodysplastic Syndromes

Blood (2015) 126 (23): 2879.

https://doi.org/10.1182/blood.V126.23.2879.2879

Published: 2015

Journal Articles

Time Changes In Predictive Power Of MDS Prognostic Scores – Effects On Revised Scores Such As The IPSS-R, Impact Of Age

Blood (2013) 122 (21): 1544.

https://doi.org/10.1182/blood.V122.21.1544.1544

Published: 2013

Journal Articles

Comprehensive Workup of Myelodysplastic Syndromes: Comparing Targeted DNA Sequencing, Oligo/SNP Microarray and Higher Dimensional Flow Cytometry.

Marilyn L Slovak, PhD, Ya-Hsuan Hsu, MS, Hseuh-Hua Chen, BS, MT, SH, Yongbao Wang, PhD, Philip N Mowrey, PhD, Charles Repetti, PhD, Albert K Ho, MD, PhD, Qiulu Pan, MD, Ila Bansal, MD, Dan Jones, MD, PhD

Blood (2012) 120 (21): 2519.

https://doi.org/10.1182/blood.V120.21.2519.2519

Published: 2012

Journal Articles

Microarray-Based Genomic Profiling Facilitates Genetic Subgrouping and Detects Critical Submicroscopic Aberrations Associated with Prognosis in Pediatric Acute Lymphoblastic Leukemia (ALL)

Marilyn L Slovak, PhD, Ya-Hsuan Hsu, MS, Jennifer A Otani-Rosa, BS, Jennifer A Jahn, BS, Zunyan Dai, PhD, Marc Sanidad, BS, Philip N Mowrey, PhD, Dan Jones, MD, PhD

Blood (2012) 120 (21): 1444.

https://doi.org/10.1182/blood.V120.21.1444.1444

Published: 2012

Journal Articles

Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18–60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG

Era L. Pogosova-Agadjanyan, Kenneth J. Kopecky, PhD, Stephen Petersdorf, MD, Harry Paul Erba, MD, PhD, Richard M. Stone, MD, Soheil Meshinchi, MD, PhD, Thomas J. Nevill, MD, FRCPC, Jerald P. Radich, MD, Leif Stenke, MD, PhD, Marilyn L Slovak, PhD, Robert K Stuart, MD, Martin S. Tallman, MD, Cheryl L Willman, MD, Rebecca M. Mortensen, Breanna L. Wentz, Frederick R. Appelbaum, MD, Derek L. Stirewalt, MD

Blood (2011) 118 (21): 2520.

https://doi.org/10.1182/blood.V118.21.2520.2520

Published: 2011

Journal Articles

Outcome and Prevalence of Hyperdiploidy and Hypodiploidy in Adults with Newly Diagnosed Acute Lymphocytic Leukemia: A SWOG Study

Anjali S. Advani, MD, Holly Gundacker, Marilyn L. Slovak, PhD, Karl S. Theil, MD, Stephen J. Forman, Jerald P. Radich, MD, Frederick R. Appelbaum, MD

Blood (2011) 118 (21): 2555.

https://doi.org/10.1182/blood.V118.21.2555.2555

Published: 2011

Journal Articles

Dissecting Clonal Diversity in Complex Leukemia Samples with Next Generation Single Nucleotide Polymorphism (SNP)-Copy Number Arrays,

Sanidad A Marc, BS, Marilyn L Slovak, PhD, Philip N Mowry, PhD, Joey C Kelly, PhD, Daniel M Jones, MD, PhD

Blood (2011) 118 (21): 3550.

https://doi.org/10.1182/blood.V118.21.3550.3550

Published: 2011

Journal Articles

Technical Standards and Guidelines for Use of Clinical Genomic Microarray Analysis in Hematopoietic and Other Neoplastic Disorders: A Draft From a Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee

Marilyn L Slovak, PhD, Daynna J Wolff, PhD, Marilyn M Li, M.D., Matthew S Lebo, PhD, Linda D Cooley, MD

Blood (2011) 118 (21): 4906.

https://doi.org/10.1182/blood.V118.21.4906.4906

Published: 2011

Journal Articles

Unrelated Clones In Myelodysplastic Syndromes and Acute Myeloid Leukemia - Characterization and Prognostic Relevance

Blood (2010) 116 (21): 4022.

https://doi.org/10.1182/blood.V116.21.4022.4022

Published: 2010

Journal Articles

SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation

Ronan Quere, PhD, Göran Karlsson, PhD, Falk Hertwig, Marianne Rissler, Beata Lindqvist, Thoas Fioretos, MD, PhD, Peter Vandenberghe, MD, PhD, Marilyn L. Slovak, PhD, Kristian Reckzeh, Jörg Cammenga, MD, PhD, Stefan Karlsson, MD, PhD

Blood (2010) 116 (21): 3153.

https://doi.org/10.1182/blood.V116.21.3153.3153

Published: 2010

Journal Articles

Targeted Microarray Analyses Augment the Clinical Cytogenetic Diagnosis of Acute Lymphoblastic Leukemia (ALL): Submicroscopic Genetic Events Improve Diagnosis, Contribute to Risk Stratification, and Provide Genetic Markers for Minimal Residual Disease (MRD) Testing

Marilyn L. Slovak, PhD, Yi Ning, PhD, Lei Yu, PhD, Stephen Hunger, MD, Andrew J. Carroll, PhD, Theresa C. Brown, PhD, Lynda J Campbell, MBBS, FRCPA, Meaghan Wall, MBBS, PhD, FRACP, FRCPA, Eric Crawford, PhD, Min Fang, M.D., Ph.D., Kathryn Kolquist, MD, Reza Saleki, PhD, Lisa G Shaffer, PhD, Blake Ballif, PhD, Roger Schultz, PhD

Blood (2010) 116 (21): 2690.

https://doi.org/10.1182/blood.V116.21.2690.2690

Published: 2010

Journal Articles

Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples

Athena M Cherry, Ph.D., Marilyn L. Slovak, PhD, Lynda J Campbell, MBBS, FRCPA, Kathy Chun, PhD, Virginie Eclache, Detlef Haase, Claudia Haferlach, MD, Anne Hagemeijer, MD, Barbara Hildebrandt, Anwar M. Iqbal, PhD, Suresh C. Jhanwar, PhD, Michelle Lebeau, Kazuma Ohyashiki, MD, PhD, Francesc Solé, PhD, Daniel L. Van Dyke, PhD, Gordon Dewald

Blood (2010) 116 (21): 2922.

https://doi.org/10.1182/blood.V116.21.2922.2922

Published: 2010

Journal Articles

Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia.

Stephen Petersdorf, MD, Kenneth Kopecky, PhD, Robert K Stuart, MD, Richard A. Larson, MD, Thomas J. Nevill, MD, FRCPC, Leif Stenke, MD, PhD, Marilyn L. Slovak, PhD, Martin S. Tallman, MD, Cheryl L. Willman, MD, Harry Erba, MD, Frederick R Appelbaum

Blood (2009) 114 (22): 790.

https://doi.org/10.1182/blood.V114.22.790.790

Published: 2009

Journal Articles

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Holly Gundacker, MS, Olga Sala-Torra, MD, Jerald Radich, MD, Raymond Lai, MD, PhD, Marilyn L. Slovak, PhD, Jeffrey E Lancet, MD, Steve Coutre, MD, Robert K Stuart, MD, Martha P. Mims, MD, PhD, Patrick Stiff, MD, Frederick R. Appelbaum, MD

Blood (2009) 114 (22): 3094.

https://doi.org/10.1182/blood.V114.22.3094.3094

Published: 2009

Journal Articles

Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study

Kathy Chun, PhD, Anne Hagemeijer, MD, Anwar Iqbal, PhD, Marilyn L. Slovak, PhD

Blood (2008) 112 (11): 2681.

https://doi.org/10.1182/blood.V112.11.2681.2681

Published: 2008

Journal Articles

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Blood (2008) 112 (11): 1649.

https://doi.org/10.1182/blood.V112.11.1649.1649

Published: 2008

Journal Articles

Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML).

Margaret R. O’Donnell, MD, Anthony S. Stein, MD, Ryotaro Nakamura, MD, Marilyn L. Slovak, PhD, Nicole Tsai, PhD, Joycelynne Palmer, PhD, Roberto Rodriguez, MD, Ricardo Spielberger, MD, Eileen P. Smith, MD, David S. Snyder, MD, Pablo M. Parker, MD, Leslie Popplewell, MD, Vinod Pullarkat, MD, Chatchada Karanes, MD, Neil Kogut, MD, George Somlo, MD, Stephen J. Forman, MD

Blood (2007) 110 (11): 1089.

https://doi.org/10.1182/blood.V110.11.1089.1089

Published: 2007

Journal Articles

Antibody-Targeted FISH Analysis Improves Detection of Residual Disease in “High Risk” B-Cell Acute Lymphoblastic Leukemia.

Marilyn L. Slovak, PhD, Elmon L. Enriquez, BS, Victoria Bedell, BS, Young Kim, MD, Qin Huang, MD, David Smith, PhD, Anthony Stein, MD, Stephen J. Forman, MD

Blood (2007) 110 (11): 3500.

https://doi.org/10.1182/blood.V110.11.3500.3500

Published: 2007

Journal Articles

Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).

Harry P. Erba, MD, PhD, Kenneth J. Kopecky, PhD, Mark H. Kirschbaum, MD, Martin S. Tallman, MD, Richard A. Larson, MD, Cheryl L. Willman, MD, Marilyn L. Slovak, PhD, Holly M. Gundacker, MA, Frederick R. Appelbaum, MD

Blood (2007) 110 (11): 440.

https://doi.org/10.1182/blood.V110.11.440.440

Published: 2007

Journal Articles

Changes in the Pattern of Cytogenetic Aberrations with Advancing Age in Acute Myeloid (Non-APL) Leukemia: A Southwest Oncology Study (S9007).

Thomas H. Norwood, MD, Holly M. Gundacker, MS, Marilyn L. Slovak, PhD, Harry Paul Erba, MD, PhD, Frederick R. Appelbaum, MD

Blood (2006) 108 (11): 808.

https://doi.org/10.1182/blood.V108.11.808.808

Published: 2006

NARROW

Prognostic Impact of Rare Single Abnormalities in Myelodysplastic Syndromes

Time Changes In Predictive Power Of MDS Prognostic Scores – Effects On Revised Scores Such As The IPSS-R, Impact Of Age

Comprehensive Workup of Myelodysplastic Syndromes: Comparing Targeted DNA Sequencing, Oligo/SNP Microarray and Higher Dimensional Flow Cytometry.

Microarray-Based Genomic Profiling Facilitates Genetic Subgrouping and Detects Critical Submicroscopic Aberrations Associated with Prognosis in Pediatric Acute Lymphoblastic Leukemia (ALL)

Prognostic Significance of FLT3 and NPM1 Mutations in Adults of Age 18–60 with De Novo Acute Myeloid Leukemia (AML) on SWOG S0106 Study: A Study by FHCRC and SWOG

Outcome and Prevalence of Hyperdiploidy and Hypodiploidy in Adults with Newly Diagnosed Acute Lymphocytic Leukemia: A SWOG Study

Dissecting Clonal Diversity in Complex Leukemia Samples with Next Generation Single Nucleotide Polymorphism (SNP)-Copy Number Arrays,

Technical Standards and Guidelines for Use of Clinical Genomic Microarray Analysis in Hematopoietic and Other Neoplastic Disorders: A Draft From a Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee

Unrelated Clones In Myelodysplastic Syndromes and Acute Myeloid Leukemia - Characterization and Prognostic Relevance

SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation

Targeted Microarray Analyses Augment the Clinical Cytogenetic Diagnosis of Acute Lymphoblastic Leukemia (ALL): Submicroscopic Genetic Events Improve Diagnosis, Contribute to Risk Stratification, and Provide Genetic Markers for Minimal Residual Disease (MRD) Testing

Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples

Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML).

Antibody-Targeted FISH Analysis Improves Detection of Residual Disease in “High Risk” B-Cell Acute Lymphoblastic Leukemia.

Phase II Studies of Different Schedules and Doses of the Farnesyl Transferase Inhibitor Tipifarnib (R115777, Zarnestra, NSC-702818) for Patients of Age 70 or Older with Previously Untreated Acute Myeloid Leukemia (AML): A North American Intergroup Study (S0432).

Changes in the Pattern of Cytogenetic Aberrations with Advancing Age in Acute Myeloid (Non-APL) Leukemia: A Southwest Oncology Study (S9007).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only